甘李药业: 第五届监事会第二次会议决议公告

Group 1 - The company held its fifth supervisory board's second meeting on July 21, 2025, with a valid resolution passed by the attending supervisors [1] - The supervisory board unanimously approved the proposal to continue using idle raised funds for cash management, allowing up to RMB 250 million for investment in safe and liquid financial products [1] - The investment products include time deposits, structured deposits, and large certificates of deposit, with a usage period not exceeding 12 months from the date of approval [1][2] Group 2 - The board's decision ensures that the use of idle funds will not affect the normal progress of the fundraising investment plan [1] - The voting results showed 3 votes in favor, with no opposition or abstentions [2]